Copy
APVS Newsletter, February 2016
View this email in your browser
Asia Pacific Vascular Society Newsletter, February 2016 (No. 22)
Latest Interesting Articles
INDUSTRY NEWS

Boston Scientific to Dsitribute Bard's Lutonix Drug Eluting Balloon


February 13, 2015 — Boston Scientific and C. R. Bard announced a deal where Boston Scientific will distribute the Lutonix 035 drug coated balloon (DCB) percutaneous transluminal angioplasty catheter in the United States under a limited distribution agreement reached with Bard. Terms of the agreement were not disclosed.
The Lutonix DCB is an angioplasty balloon coated with a therapeutic dose of the drug paclitaxel that is designed to decrease the incidence of restenosis and improve patency in patients with stenosed femoropopliteal vessels, often seen with peripheral artery disease. Lutonix DCB was the first U.S. Food and Drug Administration (FDA)-approved DCB in the United States.
For more information: www.bostonscientific.com, www.crbard.com


(Source: http://www.dicardiology.com/)
 
UPCOMING CONFERENCES:
  1. CSI- National Interventional Council (NIC) Meet, 15-17 April, 2016, Hyderabad
  2. Charing Cross Symposium, 26-29 April, 2016, London, UK
  3. 8th Asia Pacific Vascular Intervention Course / Fellows Course, 17-19 June, 2016, New Delhi
  4. TCT India Next 2016, August 4-7, 2016, New Delhi
APVIC VIII - 8th ASIA PACIFIC VASCULAR INTERVENTION COURSE / FELLOWS COURSE
17 - 19 JUNE, 2016
REGISTER NOW !
Copyright © 2016, APVS. All rights reserved.
Dr. (Prof.) N. N. Khanna
MD, DM, FRCP (Lond., Glasg., Edin.), FACC, FESC, FSCAI, FAPSIC, FEISI, FICC, FCSI, FICP
Chairman, Asia Pacific Vascular Society
Chairman, National Interventional Council, CSI
Sr. Consultant, Interventional Cardiology & Vascular Interventions
Advisor- Apollo Group of Hospitals
Indraprastha Apollo Hospitals, New Delhi
E-mail: nnkhannaapvic@gmail.com, Website: www.apvs.in, www.drnnkhanna.com

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list